Literature DB >> 10231481

Proteoglycan receptor binding by Neisseria gonorrhoeae MS11 is determined by the HV-1 region of OpaA.

C C Grant1, M P Bos, R J Belland.   

Abstract

The interaction of the OpaA protein of Neisseria gonorrhoeae MS11mk with heparan sulphate-containing proteoglycan receptors on Chang conjunctiva epithelial cells was examined using isolated receptor binding and cell adherence/internalization assays. OpaA deletion proteins, in which the four surface-exposed regions of the protein were deleted individually, and chimeric OpaA/B proteins, in which the surface-exposed regions of the OpaA and OpaB proteins were exchanged, were expressed in N. gonorrhoeae. The recombinant deletion proteins and the chimeric OpaA/B proteins were surface exposed in the outer membrane of N. gonorrhoeae. Isolated receptor-binding assays and Chang cell infection assays with OpaA deletion variants indicated that hypervariable region 1 was essential for the interaction of N. gonorrhoeae with the proteoglycan receptor. Expression of chimeric OpaA/B proteins confirmed the central role of hypervariable region 1 in receptor binding and demonstrated that this domain alone confers the invasive biological phenotype in a non-heparan sulphate proteoglycan-binding Opa protein. The other variable regions of OpaA enhanced receptor binding in the presence of region 1, but did not constitute binding domains on their own. The results indicate that proteoglycan receptor binding results from a hierarchical interaction between the variable domains of the OpaA protein of MS11mk.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10231481     DOI: 10.1046/j.1365-2958.1999.01293.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  8 in total

1.  Opacity-associated adhesin repertoire in hyperinvasive Neisseria meningitidis.

Authors:  Martin J Callaghan; Keith A Jolley; Martin C J Maiden
Journal:  Infect Immun       Date:  2006-09       Impact factor: 3.441

2.  Interaction of an uuter membrane protein of enterotoxigenic Escherichia coli with cell surface heparan sulfate proteoglycans.

Authors:  James M Fleckenstein; James T Holland; David L Hasty
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

3.  Effect of alpha-oligosaccharide phenotype of Neisseria gonorrhoeae strain MS11 on invasion of Chang conjunctival, HEC-1-B endometrial, and ME-180 cervical cells.

Authors:  S Y Minor; A Banerjee; E C Gotschlich
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

4.  Carcinoembryonic antigen family receptor recognition by gonococcal Opa proteins requires distinct combinations of hypervariable Opa protein domains.

Authors:  Martine P Bos; David Kao; Daniel M Hogan; Christopher C R Grant; Robert J Belland
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

5.  Glycointeractome of Neisseria gonorrhoeae: Identification of Host Glycans Targeted by the Gonococcus To Facilitate Adherence to Cervical and Urethral Epithelial Cells.

Authors:  Christopher J Day; Kate L Seib; Evgeny A Semchenko; Arun V Everest-Dass; Freda E-C Jen; Tsitsi D Mubaiwa
Journal:  mBio       Date:  2019-07-09       Impact factor: 7.867

6.  Neisseria meningitidis Opc invasin binds to the cytoskeletal protein alpha-actinin.

Authors:  Claudia Sa E Cunha; Natalie J Griffiths; Isabel Murillo; Mumtaz Virji
Journal:  Cell Microbiol       Date:  2008-11-07       Impact factor: 3.715

7.  Surface glycosaminoglycans mediate adherence between HeLa cells and Lactobacillus salivarius Lv72.

Authors:  Rebeca Martín; Carla Martín; Susana Escobedo; Juan E Suárez; Luis M Quirós
Journal:  BMC Microbiol       Date:  2013-09-17       Impact factor: 3.605

8.  Structure of the Neisserial outer membrane protein Opa₆₀: loop flexibility essential to receptor recognition and bacterial engulfment.

Authors:  Daniel A Fox; Per Larsson; Ryan H Lo; Brett M Kroncke; Peter M Kasson; Linda Columbus
Journal:  J Am Chem Soc       Date:  2014-05-19       Impact factor: 15.419

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.